BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26873084)

  • 1. Incidental findings of uncertain significance: To know or not to know--that is not the question.
    Hofmann B
    BMC Med Ethics; 2016 Feb; 17():13. PubMed ID: 26873084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To know or not to know? Genetic ignorance, autonomy and paternalism.
    Wilson J
    Bioethics; 2005 Oct; 19(5-6):492-504. PubMed ID: 16425486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The right to genetic ignorance confirmed.
    Takala T
    Bioethics; 1999 Jul; 13(3-4):288-93. PubMed ID: 11657239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fiduciary relationship model for managing clinical genomic "incidental" findings.
    Lázaro-Muñoz G
    J Law Med Ethics; 2014; 42(4):576-89. PubMed ID: 25565622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient rights, risk, and responsibilities in the genetic era - a right to know, a right not to know, or a duty to know?
    Domaradzki J
    Ann Agric Environ Med; 2015; 22(1):156-62. PubMed ID: 25780847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Right to Know: A Revised Standard for Reporting Incidental Findings.
    Schaefer GO; Savulescu J
    Hastings Cent Rep; 2018 Mar; 48(2):22-32. PubMed ID: 29590521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental variants are critical for genomics.
    Biesecker LG
    Am J Hum Genet; 2013 May; 92(5):648-51. PubMed ID: 23643378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing the Right Not to Know: Conceptual, Professional, and Legal Implications.
    Laurie G
    J Law Med Ethics; 2014; 42(1):53-63. PubMed ID: 26767476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining and managing incidental findings in genetic and genomic practice.
    Shkedi-Rafid S; Dheensa S; Crawford G; Fenwick A; Lucassen A
    J Med Genet; 2014 Nov; 51(11):715-23. PubMed ID: 25228303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The right to remain in ignorance about genetic information--can such a right be defended in the name of autonomy?
    Malpas P
    N Z Med J; 2005 Aug; 118(1220):U1611. PubMed ID: 16132072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freedom of Choice About Incidental Findings Can Frustrate Participants' True Preferences.
    Viberg J; Segerdahl P; Langenskiöld S; Hansson MG
    Bioethics; 2016 Mar; 30(3):203-9. PubMed ID: 25908209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.
    Townsend A; Adam S; Birch PH; Lohn Z; Rousseau F; Friedman JM
    Am J Med Genet A; 2012 Oct; 158A(10):2519-25. PubMed ID: 22903777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preferences regarding incidental genomic findings discovered during tumor profiling.
    Yushak ML; Han G; Bouberhan S; Epstein L; DiGiovanna MP; Mougalian SS; Sanft TB; Abu-Khalaf MM; Chung GG; Stein SM; Goldberg SB; Pusztai L; Hofstatter EW
    Cancer; 2016 May; 122(10):1588-97. PubMed ID: 26970385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    May T
    J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
    Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
    Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To disclose, or not to disclose? Perspectives of clinical genomics professionals toward returning incidental findings from genomic research.
    AlFayyad I; Al-Tannir M; Abu-Shaheen A; AlGhamdi S
    BMC Med Ethics; 2021 Jul; 22(1):101. PubMed ID: 34315465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings.
    Strong KA; Zusevics KL; Bick DP; Veith R
    WMJ; 2014 Oct; 113(5):179-84. PubMed ID: 25739160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.
    Lemke AA; Bick D; Dimmock D; Simpson P; Veith R
    Clin Genet; 2013 Sep; 84(3):230-6. PubMed ID: 23163796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.